Medexus Pharmaceuticals Inc.
MDP.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.73% | -72.79% | 77.41% | 34.53% | 10.39% |
| Total Receivables | 5.90% | 11.66% | -16.31% | -7.45% | -6.69% |
| Inventory | -15.63% | -7.41% | -7.96% | -10.30% | -2.38% |
| Prepaid Expenses | 48.55% | 64.26% | 21.46% | 19.91% | 0.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 18.88% | -- | -- | -- |
| Total Current Assets | -8.30% | -20.84% | 4.87% | -2.75% | -1.89% |
|
|
|||||
| Total Current Assets | -8.30% | -20.84% | 4.87% | -2.75% | -1.89% |
| Net Property, Plant & Equipment | -35.08% | -38.75% | -35.81% | -30.64% | -23.29% |
| Long-term Investments | -1.87% | 1.44% | 2.28% | -1.44% | 0.16% |
| Goodwill | -1.87% | 1.44% | 2.28% | -1.44% | 0.16% |
| Total Other Intangibles | -11.01% | -12.94% | 9.25% | 9.35% | 10.84% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.13% | 18.03% | 3.22% | 5.45% | 13.87% |
| Total Assets | -7.61% | -14.29% | 6.17% | 2.80% | 4.43% |
|
|
|||||
| Total Accounts Payable | -3.74% | 43.49% | 9.13% | 1.54% | 11.99% |
| Total Accrued Expenses | -- | 8.21% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -88.99% | -94.02% | -59.45% | 17.96% | 31.16% |
| Total Finance Division Other Current Liabilities | -73.97% | -74.87% | 33.54% | 90.27% | 141.76% |
| Total Other Current Liabilities | -73.97% | -74.87% | 33.54% | 90.27% | 141.76% |
| Total Current Liabilities | -42.78% | -44.94% | -5.95% | 18.12% | 33.18% |
|
|
|||||
| Total Current Liabilities | -42.78% | -44.94% | -5.95% | 18.12% | 33.18% |
| Long-Term Debt | -- | -- | -16.83% | -100.41% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.19% | 32.32% | -82.33% | -54.18% | -67.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.88% | 11.15% | -8.80% | -8.36% | -13.49% |
| Total Liabilities | -6.75% | -17.88% | -8.95% | -13.85% | -12.07% |
|
|
|||||
| Common Stock & APIC | -2.21% | -0.77% | 21.52% | 21.96% | 21.99% |
| Retained Earnings | -3.85% | -3.86% | -0.44% | 0.61% | 1.29% |
| Treasury Stock & Other | -2.24% | 1.21% | 5.11% | -2.81% | 0.80% |
| Total Common Equity | -9.24% | -6.05% | 57.73% | 60.10% | 62.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.24% | -6.05% | 57.73% | 60.10% | 62.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.24% | -6.05% | 57.73% | 60.10% | 62.52% |
|
|
|||||